. The prevalence of varicose
veins rose from 22.7% to 25.1% (Table X). Participants with
C2 disease increased to higher C-classes in 19.8% for

nonsaphenous varicose veins and in 31.8% for saphenous
varicose veins. The main risk factor for progression
was obesity. The Edinburgh Vein Study had a 13-year
